543 related articles for article (PubMed ID: 8840995)
21. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
Pavlinkova G; Booth BJ; Batra SK; Colcher D
Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
[TBL] [Abstract][Full Text] [Related]
23. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
[TBL] [Abstract][Full Text] [Related]
24. Swine monoclonal antibodies of high affinity and specificity to carcinoembryonic antigen.
Buchegger F; Fournier K; Schreyer M; Carrel S; Mach JP
J Natl Cancer Inst; 1987 Aug; 79(2):337-42. PubMed ID: 2439734
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of radiation therapy by tumor necrosis factor alpha in human colon cancer using a bispecific antibody.
Azria D; Dorvillius M; Gourgou S; Martineau P; Robert B; Pugnière M; Delard R; Ychou M; Dubois JB; Pèlegrin A
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1363-73. PubMed ID: 12654449
[TBL] [Abstract][Full Text] [Related]
27. Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA).
Robert B; Dorvillius M; Buchegger F; Garambois V; Mani JC; Pugnières M; Mach JP; Pèlegrin A
Int J Cancer; 1999 Apr; 81(2):285-91. PubMed ID: 10188732
[TBL] [Abstract][Full Text] [Related]
28. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
[TBL] [Abstract][Full Text] [Related]
29. Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia.
Cope DA; Dewhirst MW; Friedman HS; Bigner DD; Zalutsky MR
Cancer Res; 1990 Mar; 50(6):1803-9. PubMed ID: 2407344
[TBL] [Abstract][Full Text] [Related]
30. Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
Cardillo TM; Karacay H; Goldenberg DM; Yeldell D; Chang CH; Modrak DE; Sharkey RM; Gold DV
Clin Cancer Res; 2004 May; 10(10):3552-61. PubMed ID: 15161715
[TBL] [Abstract][Full Text] [Related]
31. Hyperthermia enhances localization of 111In-labeled hapten to bifunctional antibody in human colon tumor xenografts.
Gridley DS; Ewart KL; Cao JD; Stickney DR
Cancer Res; 1991 Mar; 51(5):1515-20. PubMed ID: 1997192
[TBL] [Abstract][Full Text] [Related]
32. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
[TBL] [Abstract][Full Text] [Related]
33. Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens.
Gautherot E; Le Doussal JM; Bouhou J; Manetti C; Martin M; Rouvier E; Barbet J
J Nucl Med; 1998 Nov; 39(11):1937-43. PubMed ID: 9829586
[TBL] [Abstract][Full Text] [Related]
34. Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice.
Buchegger F; Pèlegrin A; Delaloye B; Bischof-Delaloye A; Mach JP
J Nucl Med; 1990 Jun; 31(6):1035-44. PubMed ID: 2348233
[TBL] [Abstract][Full Text] [Related]
35. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
Milenic DE; Yokota T; Filpula DR; Finkelman MA; Dodd SW; Wood JF; Whitlow M; Snoy P; Schlom J
Cancer Res; 1991 Dec; 51(23 Pt 1):6363-71. PubMed ID: 1933899
[TBL] [Abstract][Full Text] [Related]
36. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
Ito T; Qiu H; Collins JA; Brill AB; Johnson DK; Griffin TW
Cancer Res; 1991 Jan; 51(1):255-60. PubMed ID: 1988087
[TBL] [Abstract][Full Text] [Related]
37. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
38. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
[TBL] [Abstract][Full Text] [Related]
39. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
Gestin JF; Loussouarn A; Bardiès M; Gautherot E; Gruaz-Guyon A; Saï-Maurel C; Barbet J; Curtet C; Chatal JF; Faivre-Chauvet A
J Nucl Med; 2001 Jan; 42(1):146-53. PubMed ID: 11197965
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1).
Siler K; Eggensperger D; Hand PH; Milenic DE; Miller LS; Houchens DP; Hinkle G; Schlom J
Biotechnol Ther; 1993; 4(3-4):163-81. PubMed ID: 8292968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
